WHO ICTRP trial
Collaborative treatment of primary nephrotic syndrome in children with…
ChiCTR2500101933 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500101933 |
|---|---|
| Public title | Collaborative treatment of primary nephrotic syndrome in children with traditional Chinese and Western medicine |
| Scientific title | Collaborative treatment of primary nephrotic syndrome in children with traditional Chinese and Western medicine |
| Primary sponsor | Shanghai Children’s Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Primary nephrotic syndrome |
| Interventions | Control group (Western Medicine treatment plan):Single intravenous injection of rituximab;Integrated traditional Chinese and Western medicine treatment group:Single intravenous injection of rituximab, and oral administration of the… |
| Registration date | May 6, 2025 |
| Target size | Control group (Western Medicine treatment plan):36;Integrated traditional… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: